# DIANTHUS THERAPEUTICS INC (DNTH)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/DNTH/

- Reporting holders: 5
- Reported value: $60.7K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $49.1K | 558 | 0.0% | 9 |
| [Grove Bank & Trust](https://holderbook.com/funds/1662212-grove-bank-trust/) | $5.4K | 61 | 0.0% | 3 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $4.8K | 54 | 0.0% | 5 |
| [EASTERN BANK](https://holderbook.com/funds/1126395-eastern-bank/) | $881 | 10 | 0.0% | 2 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $528 | 6 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 5 | $60.7K |
| Q2 2026 | 271 | $6.9B |
| Q1 2026 | 242 | $5.5B |
| Q4 2025 | 166 | $2.1B |
| Q3 2025 | 142 | $1.9B |
| Q2 2025 | 104 | $731.9M |
| Q1 2025 | 99 | $688.0M |
| Q4 2024 | 95 | $765.7M |
| Q3 2024 | 90 | $859.0M |
| Q2 2024 | 74 | $769.0M |
| Q1 2024 | 75 | $784.0M |
| Q4 2023 | 39 | $109.9M |